Insider buying of this magnitude ($1.0M in a single window, cumulative $3.75M with zero sales) is a strong conviction signal, especially following a 288% revenue beat and raised guidance. The $1B General Catalyst commitment and $251M IM8 run-rate provide fundamental support. Monitor for continued insider accumulation and Q3 revenue trajectory to validate the FY2027 >$400M guidance.
Price Chart
Executive Summary
Prenetics CEO Danny Yeung and CFO Brian Rosin purchased $1.0M of PRE shares in the open market between Aug 20-25, 2026, following Q2 results. Cumulative insider purchases since Nov 2025 now total ~$3.75M with zero shares sold, signaling strong conviction after the company reported 288% YoY revenue growth and raised FY2026 guidance to $220-230M. The filing also notes IM8's July revenue of $20.9M and a $1B growth financing commitment from General Catalyst.
Key Facts
- CEO and CFO purchased $1.0M of shares in open market between Aug 20-25, 2026
- Cumulative insider purchases since Nov 2025 total ~$3.75M with no shares sold
- Q2 2026 revenue of $46.5M, up ~288% YoY; IM8 revenue of $45.0M, up ~359% YoY
- FY2026 revenue guidance raised to $220-230M; FY2027 guidance introduced at >$400M
- IM8 July revenue of $20.9M, annualized run-rate ~$251M
- General Catalyst committed $1B growth financing to IM8 in July 2026
- CFO Brian Rosin made his first open market purchase since joining in May 2026
Financial Impact
CEO and CFO purchased $1.0M of shares; cumulative insider investment ~$3.75M since Nov 2025
Risk Factors
- Forward-looking guidance of >$400M for FY2027 is ambitious and depends on sustained IM8 growth trajectory
- Dependence on IM8 brand momentum and ability to maintain customer acquisition efficiency
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-058996 |
| Document: 0001628280-26-058996-index-headers.html | 0001628280-26-058996 |
| Document: 0001628280-26-058996-index.html | 0001628280-26-058996 |
| Document: 0001628280-26-058996.txt | 0001628280-26-058996 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $21.27 | awaiting T+60 | — | $18.37 (−13.63%) |
Sep 22, 2026 4w ago | F-1/A | $22.90 | awaiting T+60 | — | $18.37 (−19.78%) |
Aug 26, 2026 8w ago | 6-K | $25.78 | awaiting T+60 | — | $18.37 (−28.74%) |
Aug 26, 2026 8w ago | Insider Cluster | $25.78 | awaiting T+60 | — | $18.37 (−28.74%) |
Aug 26, 2026 8w ago | 3 | $25.78 | awaiting T+60 | — | $18.37 (−28.74%) |
Aug 20, 2026 9w ago | 6-K | $17.97 | awaiting T+60 | — | $18.37 (+2.23%) |
Aug 18, 2026 9w ago | 6-K | $19.40 | awaiting T+60 | — | $18.37 (−5.31%) |
Aug 18, 2026 9w ago | Press Release | $19.40 | awaiting T+60 | — | $18.37 (−5.31%) |
Aug 17, 2026 10w ago | 6-K | $19.37 | awaiting T+60 | — | $18.37 (−5.16%) |
Aug 7, 2026 11w ago | F-1/A | $18.26 | awaiting T+60 | — | $18.37 (+0.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers